window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : June 29, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

Digital & Data

  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Insilico Medicine signs $2.75bn AI drug discovery deal with Eli Lilly

    Insilico Medicine has signed a drug discovery collaboration with Eli [...]

    May 5, 2026
  • Digital & Data,Drug Discovery & Development,Therapeutic Areas

    Bullfrog AI signs commercial agreement with top 5 global pharma company to identify novel target in major depressive disorder

    BullFrog AI Holdings has entered a commercial agreement with a [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Ribbon CEO calls for faster adoption of AI and DNA synthesis to accelerate drug development

    The chief executive of Ribbon Biolabs has called for faster [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Genomics and sequencing,Therapeutic Areas

    Primerdesign and Origin partner on rectal mucus DNA extraction for colorectal cancer detection

    Primerdesign and Origin Sciences partner to develop a DNA extraction [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development,Therapeutic Areas

    insitro and Bristol Myers Squibb expand ALS targets in AI collaboration

    insitro and Bristol Myers Squibb have expanded their ALS collaboration [...]

    May 5, 2026
  • Digital & Data,Therapeutic Areas

    Insilico nominates pan-KRAS candidate ISM6166 after tumour regression in preclinical studies

    Insilico Medicine has nominated ISM6166 as a preclinical candidate, positioning [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Therapeutic Areas

    SPT Labtech and Illumina to develop automated platform for decentralised oncology genomics

    SPT Labtech has entered a strategic collaboration with Illumina to [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Opinion & Events,Therapeutic Areas

    Young adults in US, UK and Australia hit hardest by global mental health decline

    Young adults in wealthy countries are four times more likely [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Delivery & Formulation,Therapeutic Areas

    Study confirms Nerivio REN wearable safe with continuous glucose monitoring devices

    A new study confirms that Theranica’s Nerivio REN wearable for [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Pharmaceuticals and therapeutics

    Brainomix extends Series C to $25.4M to support US expansion

    Brainomix has extended its Series C financing by $6.5M (£4.8M), [...]

    May 5, 2026
Previous456Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • NICE recommends NHS access to teplizumab for early type 1 diabetes
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Therapeutic Areas
  • InduPro licenses Lonza ADC technology for oncology programmes
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics
  • Bionyra launches with $165M Series A to advance immunology biologics pipeline
    Categories: Biotech & Pharma Business, Drug Discovery & Development, Pharmaceuticals and therapeutics
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details. OK
Go to Top